eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort

Ramón Teira(Hospital Sierrallana), Núria Espinosa, Juan Berenguer(Instituto de Salud Carlos III), Helena Díaz-Cuervo(Gilead Sciences (Spain)), Pepa Galindo(Hospital Clínico Universitario de Valencia), Marta Montero, Alberto Romero-Palacios(Hospital Universitario Puerto Real), Peré Domingo(Hospital de Sant Pau), Elisa Martínez(University Hospital and Clinics), Elisabeth Deig(Hospital General de Granollers), Manuel Castaño, Paloma Geijo(Hospital Virgen de la Luz), Filipa Aragão(Universidade Nova de Lisboa), María Antonia Sepúlveda(Hospital Virgen de la Salud), Josefa Muñoz(Hospital de Basurto), Belén de la Fuente(Hospital Universitario De Cabueñes), Bernardino Roca(Hospital General Universitari de Castelló), Joaquim Peraire(Instituto de Salud Carlos III), Josefina García(Santa Lucía University General Hospital), MaríaDolores Merino(Hospital Juan Ramón Jiménez), Vicente Estrada(Instituto de Salud Carlos III)
HIV Research & Clinical Practice
May 4, 2021
10.1080/25787489.2021.1955197
Cited by 3

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423